Global Cancer Diagnostics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	170 Pages	TechNavio	July, 2024	INF19033861

Best Price Guarantee
Price	from $2,500
Length	170 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033861

Global Cancer Diagnostics Market 2024-2028

The cancer diagnostics market is forecasted to grow by USD 17744.5 mn during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the cancer diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of cancer, demand for personalized medicines, and need for cost-cutting in drug discovery and development.

Technavio's cancer diagnostics market is segmented as below:

By End-user

Hospitals and clinics
Diagnostic laboratories

By Type

IVD
Imaging
LDT

By Geographical Landscape

North America
Europe
APAC
Rest of World (ROW)

This study identifies the increase in r and d and advances in technology as one of the prime reasons driving the cancer diagnostics market growth during the next few years. Also, adoption of various strategies like licensing agreements and commercializing products and vendors focusing on emerging countries with large populations to expand their presence will lead to sizable demand in the market.

The report on the cancer diagnostics market covers the following areas:

Cancer diagnostics market sizing
Cancer diagnostics market forecast
Cancer diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading CANCER diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Astellas Pharma Inc., Becton Dickinson and Co., bioMerieux SA, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., General Electric Co., GlaxoSmithKline PLC, Hologic Inc., Illumina Inc., Merck KGaA, Myriad Genetics Inc., Novartis AG, Pfizer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc.. Also, the CANCER diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Cancer Diagnostics Market 2018 - 2022; Historic Market Size - Data Table on Global Cancer Diagnostics Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Hospitals and clinics - Market size and forecast 2023-2028; Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million); Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million); Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%); Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%); 6.4 Diagnostic laboratories - Market size and forecast 2023-2028; Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million); Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million); Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%); Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 IVD - Market size and forecast 2023-2028; Chart on IVD - Market size and forecast 2023-2028 ($ million); Data Table on IVD - Market size and forecast 2023-2028 ($ million); Chart on IVD - Year-over-year growth 2023-2028 (%); Data Table on IVD - Year-over-year growth 2023-2028 (%); 7.4 Imaging - Market size and forecast 2023-2028; Chart on Imaging - Market size and forecast 2023-2028 ($ million); Data Table on Imaging - Market size and forecast 2023-2028 ($ million); Chart on Imaging - Year-over-year growth 2023-2028 (%); Data Table on Imaging - Year-over-year growth 2023-2028 (%); 7.5 LDT - Market size and forecast 2023-2028; Chart on LDT - Market size and forecast 2023-2028 ($ million); Data Table on LDT - Market size and forecast 2023-2028 ($ million); Chart on LDT - Year-over-year growth 2023-2028 (%); Data Table on LDT - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 APAC - Market size and forecast 2023-2028; Chart on APAC - Market size and forecast 2023-2028 ($ million); Data Table on APAC - Market size and forecast 2023-2028 ($ million); Chart on APAC - Year-over-year growth 2023-2028 (%); Data Table on APAC - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 Agilent Technologies Inc.; Agilent Technologies Inc. - Overview; Agilent Technologies Inc. - Business segments; Agilent Technologies Inc. - Key news; Agilent Technologies Inc. - Key offerings; Agilent Technologies Inc. - Segment focus; 12.5 Becton Dickinson and Co.; Becton Dickinson and Co. - Overview; Becton Dickinson and Co. - Business segments; Becton Dickinson and Co. - Key news; Becton Dickinson and Co. - Key offerings; Becton Dickinson and Co. - Segment focus; 12.6 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.7 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key news; Eli Lilly and Co. - Key offerings; 12.8 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.9 General Electric Co.; General Electric Co. - Overview; General Electric Co. - Business segments; General Electric Co. - Key news; General Electric Co. - Key offerings; General Electric Co. - Segment focus; 12.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.11 Hologic Inc.; Hologic Inc. - Overview; Hologic Inc. - Business segments; Hologic Inc. - Key news; Hologic Inc. - Key offerings; Hologic Inc. - Segment focus; 12.12 Illumina Inc.; Illumina Inc. - Overview; Illumina Inc. - Business segments; Illumina Inc. - Key news; Illumina Inc. - Key offerings; Illumina Inc. - Segment focus; 12.13 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; 12.14 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.15 QIAGEN NV; QIAGEN NV - Overview; QIAGEN NV - Product / Service; QIAGEN NV - Key news; QIAGEN NV - Key offerings; 12.16 Quest Diagnostics Inc.; Quest Diagnostics Inc. - Overview; Quest Diagnostics Inc. - Business segments; Quest Diagnostics Inc. - Key offerings; Quest Diagnostics Inc. - Segment focus; 12.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Cancer Diagnostics Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by End-user ($ million); Exhibits45: Data Table on Market opportunity by End-user ($ million); Exhibits46: Chart on Type - Market share 2023-2028 (%); Exhibits47: Data Table on Type - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Type; Exhibits49: Data Table on Comparison by Type; Exhibits50: Chart on IVD - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on IVD - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on IVD - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on IVD - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Imaging - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Imaging - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Imaging - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Imaging - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on LDT - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on LDT - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on LDT - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on LDT - Year-over-year growth 2023-2028 (%); Exhibits62: Market opportunity by Type ($ million); Exhibits63: Data Table on Market opportunity by Type ($ million); Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits67: Chart on Geographic comparison; Exhibits68: Data Table on Geographic comparison; Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on APAC - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on APAC - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on APAC - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on APAC - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits105: Market opportunity By Geographical Landscape ($ million); Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits107: Impact of drivers and challenges in 2023 and 2028; Exhibits108: Overview on criticality of inputs and factors of differentiation; Exhibits109: Overview on factors of disruption; Exhibits110: Impact of key risks on business; Exhibits111: Companies covered; Exhibits112: Matrix on companies position and classification; Exhibits113: Abbott Laboratories - Overview; Exhibits114: Abbott Laboratories - Business segments; Exhibits115: Abbott Laboratories - Key news; Exhibits116: Abbott Laboratories - Key offerings; Exhibits117: Abbott Laboratories - Segment focus; Exhibits118: Agilent Technologies Inc. - Overview; Exhibits119: Agilent Technologies Inc. - Business segments; Exhibits120: Agilent Technologies Inc. - Key news; Exhibits121: Agilent Technologies Inc. - Key offerings; Exhibits122: Agilent Technologies Inc. - Segment focus; Exhibits123: Becton Dickinson and Co. - Overview; Exhibits124: Becton Dickinson and Co. - Business segments; Exhibits125: Becton Dickinson and Co. - Key news; Exhibits126: Becton Dickinson and Co. - Key offerings; Exhibits127: Becton Dickinson and Co. - Segment focus; Exhibits128: Bristol Myers Squibb Co. - Overview; Exhibits129: Bristol Myers Squibb Co. - Product / Service; Exhibits130: Bristol Myers Squibb Co. - Key news; Exhibits131: Bristol Myers Squibb Co. - Key offerings; Exhibits132: Eli Lilly and Co. - Overview; Exhibits133: Eli Lilly and Co. - Product / Service; Exhibits134: Eli Lilly and Co. - Key news; Exhibits135: Eli Lilly and Co. - Key offerings; Exhibits136: F. Hoffmann La Roche Ltd. - Overview; Exhibits137: F. Hoffmann La Roche Ltd. - Business segments; Exhibits138: F. Hoffmann La Roche Ltd. - Key news; Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits141: General Electric Co. - Overview; Exhibits142: General Electric Co. - Business segments; Exhibits143: General Electric Co. - Key news; Exhibits144: General Electric Co. - Key offerings; Exhibits145: General Electric Co. - Segment focus; Exhibits146: GlaxoSmithKline Plc - Overview; Exhibits147: GlaxoSmithKline Plc - Business segments; Exhibits148: GlaxoSmithKline Plc - Key news; Exhibits149: GlaxoSmithKline Plc - Key offerings; Exhibits150: GlaxoSmithKline Plc - Segment focus; Exhibits151: Hologic Inc. - Overview; Exhibits152: Hologic Inc. - Business segments; Exhibits153: Hologic Inc. - Key news; Exhibits154: Hologic Inc. - Key offerings; Exhibits155: Hologic Inc. - Segment focus; Exhibits156: Illumina Inc. - Overview; Exhibits157: Illumina Inc. - Business segments; Exhibits158: Illumina Inc. - Key news; Exhibits159: Illumina Inc. - Key offerings; Exhibits160: Illumina Inc. - Segment focus; Exhibits161: Merck KGaA - Overview; Exhibits162: Merck KGaA - Business segments; Exhibits163: Merck KGaA - Key news; Exhibits164: Merck KGaA - Key offerings; Exhibits165: Merck KGaA - Segment focus; Exhibits166: Novartis AG - Overview; Exhibits167: Novartis AG - Business segments; Exhibits168: Novartis AG - Key news; Exhibits169: Novartis AG - Key offerings; Exhibits170: Novartis AG - Segment focus; Exhibits171: QIAGEN NV - Overview; Exhibits172: QIAGEN NV - Product / Service; Exhibits173: QIAGEN NV - Key news; Exhibits174: QIAGEN NV - Key offerings; Exhibits175: Quest Diagnostics Inc. - Overview; Exhibits176: Quest Diagnostics Inc. - Business segments; Exhibits177: Quest Diagnostics Inc. - Key offerings; Exhibits178: Quest Diagnostics Inc. - Segment focus; Exhibits179: Thermo Fisher Scientific Inc. - Overview; Exhibits180: Thermo Fisher Scientific Inc. - Business segments; Exhibits181: Thermo Fisher Scientific Inc. - Key news; Exhibits182: Thermo Fisher Scientific Inc. - Key offerings; Exhibits183: Thermo Fisher Scientific Inc. - Segment focus; Exhibits184: Inclusions checklist; Exhibits185: Exclusions checklist; Exhibits186: Currency conversion rates for US$; Exhibits187: Research methodology; Exhibits188: Information sources; Exhibits189: Data validation; Exhibits190: Validation techniques employed for market sizing; Exhibits191: Data synthesis; Exhibits192: 360 degree market analysis; Exhibits193: List of abbreviations